Efficacy and safety of sildenafil treatment in pulmonary arterial hypertension: a systematic review.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

To evaluate the safety and efficacy of using sildenafil for ≥ 12 weeks to treat pulmonary arterial hypertension (PAH).

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Respir Med

Title: Respiratory medicine

Publisher: Elsevier BV

ISSN (Electronic): 1532-3064

ISSN (Print): 0954-6111

Publication date (Electronic): Mar 2014

Volume: 108

Issue: 3

Affiliations

[1 ] Department of Respiratory Medicine, West China Medical School and West China Hospital, Sichuan University, No. 3, Guo Xie Xiang, Chengdu, Sichuan 610000, China.

[2 ] Department of Respiratory Medicine, West China Medical School and West China Hospital, Sichuan University, No. 3, Guo Xie Xiang, Chengdu, Sichuan 610000, China. Electronic address: liangzongan@hotmail.com.

Article

Publisher Item ID: S0954-6111(14)00023-7

DOI: 10.1016/j.rmed.2014.01.003

PubMed ID: 24462476

SO-VID: 4972a5b0-72c8-476d-8d6f-576cdf07fb32

History

Keywords: Pulmonary arterial hypertension,Pulmonary hypertension,Sildenafil,Systematic review

Data availability:

Keywords: Pulmonary arterial hypertension, Pulmonary hypertension, Sildenafil, Systematic review

Efficacy and safety of sildenafil treatment in pulmonary arterial hypertension: a systematic review.

Read this article at

Abstract

Related collections

Efficacy of Communicating Science

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Cited by 17